Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
COYA
#3330
Coya Therapeutics, Inc. Common Stock
4.9
6
+1.22%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+1.22%
Mudança mensal
+2.06%
Mudança em 6 meses
-25.30%
Mudança anual
-24.04%
Fechamento anterior
4.9
0
Open
4.9
6
Bid
Ask
Low
4.9
6
High
4.9
6
Volume
2
Mercados
Ações
Cuidados de saúde
COYA
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
16.71 M
16.72 M
16.72 M
16.73 M
20.92 M
—
Valuation ratios
Enterprise value
76.66 M
57.53 M
72.71 M
66.37 M
91.17 M
287.78 M
Price to earnings ratio
-9.77
-5.85
-6.05
-4.64
-5.14
-21.67
Price to sales ratio
7.75
24.57
26.01
226.96
23.91
301.44
Price to cash flow ratio
-8.6
-8.49
-6.44
-5.53
-7.7
-28.15
Price to book ratio
0.68
2.21
0.71
0.68
0.72
4.31
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.11
-0.07
-0.19
-0.18
-0.07
-0.5
Return on equity %
-0.13
-0.07
-0.22
-0.22
-0.08
-0.59
Return on invested capital %
—
—
-1 557.19
-3 149.88
-998.9
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-209.03 K
-2 976.89
-3 920.47
-68.26
-216 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
-149.37 K
-2 833.35
-3 725.17
-59.36
-155.99 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
15.31
11.59
8.84
7.43
8.73
36.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0.01
0
0.11
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.36
-0.16
-0.17
-0.35
-0.07
-0.74
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.04
2.51
2.12
1.78
1.68
8.1
Net current asset value per share
2.33
2.91
2.29
2
1.91
9.12
Tangible book value per share
2.1
2.6
2
1.69
1.63
7.92
Working capital per share
2.18
2.66
2.04
1.73
1.69
8.12
Book value per share
2.1
2.6
2
1.69
1.63
7.92
Notícias
H.C. Wainwright conferma il rating Buy su Coya Therapeutics con target di $18
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target
Coya Therapeutics ottiene 11,1 milioni di dollari tramite posizionamento privato
Coya Therapeutics secures $11.1 million in private placement
Coya Therapeutics advances ALS and FTD clinical trials in 2026
H.C. Wainwright conferma rating Buy su Coya Therapeutics con target a $18
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18
Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)
H.C. Wainwright conferma il rating Buy sulle azioni di Coya Therapeutics
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock
H.C. Wainwright riconferma il rating Buy sulle azioni di Coya Therapeutics con target di $18
H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target